These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 34899716)

  • 1. Vitamin C, From Supplement to Treatment: A Re-Emerging Adjunct for Cancer Immunotherapy?
    Kouakanou L; Peters C; Brown CE; Kabelitz D; Wang LD
    Front Immunol; 2021; 12():765906. PubMed ID: 34899716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose vitamin C enhances cancer immunotherapy.
    Magrì A; Germano G; Lorenzato A; Lamba S; Chilà R; Montone M; Amodio V; Ceruti T; Sassi F; Arena S; Abrignani S; D'Incalci M; Zucchetti M; Di Nicolantonio F; Bardelli A
    Sci Transl Med; 2020 Feb; 12(532):. PubMed ID: 32102933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative view on vitamin C effects on αβ- versus γδ T-cell activation and differentiation.
    Peters C; Kouakanou L; Kabelitz D
    J Leukoc Biol; 2020 Jun; 107(6):1009-1022. PubMed ID: 32034803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV.
    Liu D; Tian S; Zhang K; Xiong W; Lubaki NM; Chen Z; Han W
    Protein Cell; 2017 Dec; 8(12):861-877. PubMed ID: 28488245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of sepsis-induced organ injury in mice by vitamin C.
    Fisher BJ; Kraskauskas D; Martin EJ; Farkas D; Puri P; Massey HD; Idowu MO; Brophy DF; Voelkel NF; Fowler AA; Natarajan R
    JPEN J Parenter Enteral Nutr; 2014 Sep; 38(7):825-39. PubMed ID: 23917525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin C treatment attenuates hemorrhagic shock related multi-organ injuries through the induction of heme oxygenase-1.
    Zhao B; Fei J; Chen Y; Ying YL; Ma L; Song XQ; Huang J; Chen EZ; Mao EQ
    BMC Complement Altern Med; 2014 Nov; 14():442. PubMed ID: 25387896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reformation in chimeric antigen receptor based cancer immunotherapy: Redirecting natural killer cell.
    Lin C; Zhang J
    Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):200-215. PubMed ID: 29378229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering chimeric antigen receptor-natural killer cells for cancer immunotherapy.
    Zhao Y; Zhou X
    Immunotherapy; 2020 Jun; 12(9):653-664. PubMed ID: 32436428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities.
    Hu W; Wang G; Huang D; Sui M; Xu Y
    Front Immunol; 2019; 10():1205. PubMed ID: 31214177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of vitamin C is tissue specific with early saturation of the brain and adrenal glands following differential oral dose regimens in guinea pigs.
    Hasselholt S; Tveden-Nyborg P; Lykkesfeldt J
    Br J Nutr; 2015 May; 113(10):1539-49. PubMed ID: 25865869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High dose oral vitamin C and mesenchymal stem cells aid wound healing in a diabetic mouse model.
    Chokesuwattanaskul S; Sukpat S; Duangpatra J; Buppajarntham S; Decharatanachart P; Mutirangura A; Patumraj S
    J Wound Care; 2018 May; 27(5):334-339. PubMed ID: 29738298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review).
    Hoskin DW; Mader JS; Furlong SJ; Conrad DM; Blay J
    Int J Oncol; 2008 Mar; 32(3):527-35. PubMed ID: 18292929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin C Fosters the
    Oyarce K; Campos-Mora M; Gajardo-Carrasco T; Pino-Lagos K
    Front Immunol; 2018; 9():112. PubMed ID: 29479348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Germline Variants in Natural Killer Cells With Tumor Immune Microenvironment Subtypes, Tumor-Infiltrating Lymphocytes, Immunotherapy Response, Clinical Outcomes, and Cancer Risk.
    Xu X; Li J; Zou J; Feng X; Zhang C; Zheng R; Duanmu W; Saha-Mandal A; Ming Z; Wang E
    JAMA Netw Open; 2019 Sep; 2(9):e199292. PubMed ID: 31483464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer cells as a double-edged sword in cancer immunotherapy: A comprehensive review from cytokine therapy to adoptive cell immunotherapy.
    Wu Y; Li J; Jabbarzadeh Kaboli P; Shen J; Wu X; Zhao Y; Ji H; Du F; Zhou Y; Wang Y; Zhang H; Yin J; Wen Q; Cho CH; Li M; Xiao Z
    Pharmacol Res; 2020 May; 155():104691. PubMed ID: 32070721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chimeric antigen receptor engineering: a right step in the evolution of adoptive cellular immunotherapy.
    Figueroa JA; Reidy A; Mirandola L; Trotter K; Suvorava N; Figueroa A; Konala V; Aulakh A; Littlefield L; Grizzi F; Rahman RL; Jenkins MR; Musgrove B; Radhi S; D'Cunha N; D'Cunha LN; Hermonat PL; Cobos E; Chiriva-Internati M
    Int Rev Immunol; 2015 Mar; 34(2):154-87. PubMed ID: 25901860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospects for personalized combination immunotherapy for solid tumors based on adoptive cell therapies and immune checkpoint blockade therapies.
    Kato D; Yaguchi T; Iwata T; Morii K; Nakagawa T; Nishimura R; Kawakami Y
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(1):68-77. PubMed ID: 28539557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reprogramming Immune Cells for Enhanced Cancer Immunotherapy: Targets and Strategies.
    Dong Y; Wan Z; Gao X; Yang G; Liu L
    Front Immunol; 2021; 12():609762. PubMed ID: 33968014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-affinity CD16-polymorphism and Fc-engineered antibodies enable activity of CD16-chimeric antigen receptor-modified T cells for cancer therapy.
    Rataj F; Jacobi SJ; Stoiber S; Asang F; Ogonek J; Tokarew N; Cadilha BL; van Puijenbroek E; Heise C; Duewell P; Endres S; Klein C; Kobold S
    Br J Cancer; 2019 Jan; 120(1):79-87. PubMed ID: 30429531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NK cell-based cancer immunotherapy: from basic biology to clinical application.
    Li Y; Yin J; Li T; Huang S; Yan H; Leavenworth J; Wang X
    Sci China Life Sci; 2015 Dec; 58(12):1233-45. PubMed ID: 26588912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.